Considerable on MSN

GSK buys Rapt in $2.2B deal

GSK agreed to acquire Rapt Therapeutics for $2.2 billion on Tuesday, a move that ...

Reassessing GSK (LSE:GSK) After 46% Share Price Jump And Pipeline Updates

If you are wondering whether GSK shares still offer value at around £18.86, you are not alone. The stock has been attracting ...
MM&M

GSK launches gynecological cancer initiative after survey reveals care gaps

There is a significant gap in patients’ understanding of treatment options for gynecologic cancers, according to a survey conducted by The Harris Poll on behalf of GSK. In a poll of more than 800 ...
STAT

FDA questions safety of GSK’s multiple myeloma drug

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
Business Insider

GSK application to expand use of Nucala to COPD accepted for review by EMA

GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal antibody that targets interleukin-5, as an add-on ...
Seeking Alpha

GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy'

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation unjustified, leading to a "Strong Buy" rating. The company’s diversified portfolio ...